UMIN-CTR Clinical Trial

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000014245
Receipt No. R000016594
Official scientific title of the study The exploratory study for the drug-predictive markers of TS-1 in metastatic or recurrent breast cancer; Translational biomarker study of SELECT BC trial
Date of disclosure of the study information 2014/06/12
Last modified on 2018/10/12 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The exploratory study for the drug-predictive markers of TS-1 in metastatic or recurrent breast cancer; Translational biomarker study of SELECT BC trial
Title of the study (Brief title) SELECT BC - the better drug predictive
marker analysis (SELECT BC-EURECA)
Region
Japan

Condition
Condition Metastatic or recurrent breast cancer
Classification by specialty
Hematology and clinical oncology Breast surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To find the predictive biomarkers of TS-1 for the breast cancer based on expression of mRNA related with 5-FU metabolism using samples from patients who participated in SELECT BC trial
Basic objectives2 Others
Basic objectives -Others Transralational research for predictive biomarker of TS-1
Trial characteristics_1 Exploratory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Correlation between the bio-marker and clinical efficacy, i.e. PFS: progression free survival, of each patient who has participated in SELECT BC trial
Key secondary outcomes Correlation between the bio-marker and clinical efficacy, i.e. TTF:Time to Treatment Failure, OS:Overall survival, and DCR:Disease control rate, of each patient who has participated in SELECT BC trial

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
75 years-old >=
Gender Female
Key inclusion criteria 1) Institutional review board (IRB) approval for research and transportation of breast cancer samples

2) Availability to obtain surgical specimen or core needle biopsy sample of breast cancer
Key exclusion criteria 1) Patients not adequate for participation in this study at doctors' discretion.

2) Patients not obtained informed consentnot obtained informed consent
Target sample size 140

Research contact person
Name of lead principal investigator Fumikata Hara
Organization National Hospital Organization Shikoku Cancer Center
Division name Department of breast oncology
Address 160 Kou, Minamiumemoto-chou, Matsuyama
TEL 089-999-1111
Email hfumikat@shikoku-cc.go.jp

Public contact
Name of contact person Akira Yamao
Organization Public Health Research Foundation
Division name Comprehensive Support Project for Oncology Research
Address 1-1-7, Nishiwaseda, Shinjyuku-ku Tokyo,
TEL 03-5287-2636
Homepage URL http://www.csp.or.jp/
Email support@csp.or.jp

Sponsor
Institute SELECT BC executive committee
Institute
Department

Funding Source
Organization Public Health Research Foundation
Organization
Division
Category of Funding Organization Non profit foundation
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor None
Name of secondary funder(s) None

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 06 Month 12 Day

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2014 Year 02 Month 10 Day
Anticipated trial start date
2014 Year 02 Month 10 Day
Last follow-up date
2015 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information Not applicable

Management information
Registered date
2014 Year 06 Month 12 Day
Last modified on
2018 Year 10 Month 12 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016594